{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T16:58:17Z","timestamp":1778259497464,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca PLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.trre.2025.100966","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:10:18Z","timestamp":1759540218000},"page":"100966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["An update on SARS-CoV-2 prevention strategy in solid organ transplant recipients: an expert opinion"],"prefix":"10.1016","volume":"39","author":[{"given":"Paolo Antonio","family":"Grossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Burra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Grandaliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Potena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizio","family":"Vitulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2025.100966_bb0005","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1111\/ajt.16428","article-title":"Incidence and outcome of SARS-CoV-2 infection on solid organ transplantation recipients: a nationwide population-based study","volume":"21","author":"Trapani","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2025.100966_bb0010","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1111\/ajt.17128","article-title":"Tixagevimab\/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave","volume":"22","author":"Al Jurdi","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2025.100966_bb0015","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1111\/ajt.17142","article-title":"Outcomes following SARS-CoV-2 infection in individuals with and without solid organ transplantation-a Danish nationwide cohort study","volume":"22","author":"Overvad","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2025.100966_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112308","article-title":"The changing health impact of vaccines in the COVID-19 pandemic: a modeling study","volume":"42","author":"Cohen","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.trre.2025.100966_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/v14102299","article-title":"Immune response after the fourth dose of SARS-CoV-2 mRNA vaccine compared to natural infection in three doses\u2019 vaccinated solid organ transplant recipients","volume":"14","author":"Bus\u00e0","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.trre.2025.100966_bb0030","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.idc.2023.03.002","article-title":"COVID-19 prevention in solid organ transplant recipients: current state of the evidence","volume":"37","author":"Vafea","year":"2023","journal-title":"Infect Dis Clin N Am"},{"key":"10.1016\/j.trre.2025.100966_bb0035","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa2116620","article-title":"Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for prevention of Covid-19","volume":"386","author":"Levin","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2025.100966_bb0040","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/cid\/ciac855","article-title":"Effectiveness of Evusheld in immunocompromised patients: propensity score-matched analysis","volume":"76","author":"Najjar-Debbiny","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trre.2025.100966_bb0045","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.kint.2022.07.008","article-title":"COVID-19 morbidity decreases with tixagevimab-cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders","volume":"102","author":"Kaminski","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2025.100966_bb0050","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.kint.2022.05.007","article-title":"Efficacy of anti-SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the omicron variant of COVID-19 in kidney transplant recipients","volume":"102","author":"Bertrand","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2025.100966_bb0055","article-title":"Monoclonal antibodies for pre- and postexposure prophylaxis of COVID-19","volume":"11","author":"Vita","year":"2022","journal-title":"Rev Literature Pathogens"},{"key":"10.1016\/j.trre.2025.100966_bb0060","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S2213-2600(22)00180-1","article-title":"Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"10","author":"Montgomery","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.trre.2025.100966_bb0065","doi-asserted-by":"crossref","first-page":"S810","DOI":"10.1093\/ofid\/ofab466.1646","article-title":"LB5. PROVENT: phase 3 study of efficacy and safety of AZD7442 (Tixagevimab\/Cilgavimab) for pre-exposure prophylaxis of COVID-19 in adults","volume":"8","author":"Levin","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.trre.2025.100966_bb0070","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001485","article-title":"Pre-exposure prophylaxis with Tixagevimab-cilgavimab did not reduce severity of COVID-19 in lung transplant recipients with breakthrough infection","volume":"9","author":"Sindu","year":"2023","journal-title":"Transplant Direct"},{"key":"10.1016\/j.trre.2025.100966_bb0075","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3390\/microorganisms12071436","article-title":"Tixagevimab\/Cilgavimab as SARS-CoV-2 pre-exposure prophylaxis in lung transplant recipients during the OmicronWave: a real-world monocentric experience","volume":"12","author":"Cona","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.trre.2025.100966_bb0080","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.kint.2022.05.008","article-title":"Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the omicron variant","volume":"102","author":"Benotmane","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2025.100966_bb0085","author":"Kavigale | EMA"},{"key":"10.1016\/j.trre.2025.100966_bb0090","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad500.1192","article-title":"The SARS-CoV-2 monoclonal antibody AZD3152 potently neutralizes historical and emerging variants and is being developed for the prevention and treatment of COVID-19 in high-risk individuals","volume":"10","author":"Francica","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.trre.2025.100966_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ado2817","article-title":"AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults","volume":"16","author":"Cai","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.trre.2025.100966_bb0100","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1473-3099(24)00804-1","article-title":"Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial","volume":"25","author":"Haidar","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.trre.2025.100966_bb0105","article-title":"Immunocompromised individuals remain at risk of COVID-19: 2023 results from the observational INFORM study","volume":"90","author":"Quint","year":"2025","journal-title":"J Inf Secur"},{"key":"10.1016\/j.trre.2025.100966_bb0110","article-title":"Impact of COVID-19 on immunocompromised populations during the omicron era: insights from the observational population-based INFORM study","volume":"35","author":"Evans","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.trre.2025.100966_bb0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/TP.0000000000003523","article-title":"COVID-19 and solid organ transplantation: a review article","volume":"105","author":"Azzi","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2025.100966_bb0120","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13853","article-title":"Impact of solid organ transplant status on outcomes of hospitalized patients with COVID-19 infection","volume":"24","author":"Schaenman","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2025.100966_bb0125","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1097\/TP.0000000000004162","article-title":"COVID-19 clinical outcomes in solid organ transplant recipients during the omicron surge","volume":"106","author":"Cochran","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2025.100966_bb0130","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/08998280.2024.2325310","article-title":"Early pandemic in-hospital outcomes and mortality risk factors in COVID-19 solid organ transplant patients","volume":"37","author":"Alhuneafat","year":"2024","journal-title":"Proc (Baylor Univ Med Cent)"},{"key":"10.1016\/j.trre.2025.100966_bb0135","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cmi.2022.12.004","article-title":"Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis","volume":"29","author":"Chen","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.trre.2025.100966_bb0140","article-title":"Optimizing the use of nirmatrelvir\/ritonavir in solid organ transplant recipients with COVID-19: a review of immunosuppressant adjustment strategies","volume":"14","author":"Tang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.trre.2025.100966_bb0145","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1053\/j.ajkd.2022.01.001","article-title":"Special considerations for Paxlovid treatment among transplant recipients with SARS-CoV-2 infection","volume":"79","author":"Fishbane","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2025.100966_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.liver.2021.100026","article-title":"COVID-19 in liver transplant recipients","volume":"3","author":"Piedade","year":"2021","journal-title":"J Liver Transpl"},{"key":"10.1016\/j.trre.2025.100966_bb0155","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.nefro.2021.05.005","article-title":"Remdesivir in kidney transplant patients with SARS-CoV-2 pneumonia","volume":"42","author":"Cacho","year":"2022","journal-title":"Nefrologia"},{"key":"10.1016\/j.trre.2025.100966_bb0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.37201\/req\/s01.07.2023","article-title":"Clinical experience in the treatment of COVID-19 with monoclonal antibodies in solid organ transplant recipients","volume":"36","author":"M\u00fa\u00f1ez-Rubio","year":"2023","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.trre.2025.100966_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104990","article-title":"Humoral immune responses against SARS-CoV-2 spike variants after mRNA vaccination in solid organ transplant recipients","volume":"25","author":"Tauzin","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.trre.2025.100966_bb0170","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/ajt.16615","article-title":"Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus","volume":"21","author":"Grupper","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2025.100966_bb0175","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/cid\/ciad016","article-title":"Relationship between immune response to severe acute respiratory syndrome coronavirus 2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort","volume":"76","author":"Bonazzetti","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trre.2025.100966_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11030755","article-title":"Effect of a fourth dose of mRNA vaccine and of immunosuppression in preventing SARS-CoV-2 breakthrough infections in heart transplant patients","volume":"11","author":"Masetti","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.trre.2025.100966_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11154475","article-title":"Impact of SARS-CoV-2 pandemic on the Management of Patients with hepatocellular carcinoma","volume":"11","author":"Guarino","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.trre.2025.100966_bb0190","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.7326\/M21-1341","article-title":"Safety and immunogenicity of anti-SARS-CoV-2 messenger RNA vaccines in recipients of solid organ transplants","volume":"174","author":"Marion","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.trre.2025.100966_bb0195","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.6822","article-title":"Immunogenicity and risk factors associated with poor humoral immune response of SARS-CoV-2 vaccines in recipients of solid organ transplant: a systematic review and Meta-analysis","volume":"5","author":"Manothummetha","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.trre.2025.100966_bb0200","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/TP.0000000000004140","article-title":"A fourth dose of COVID-19 vaccine does not induce neutralization of the omicron variant among solid organ transplant recipients with suboptimal vaccine response","volume":"106","author":"Karaba","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2025.100966_bb0205","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001670","article-title":"Comparison of COVID-19 hospitalization and death between solid organ transplant recipients and the general population in Canada, 2020-2022","volume":"10","author":"Naylor","year":"2024","journal-title":"Transplant Direct"},{"key":"10.1016\/j.trre.2025.100966_bb0210","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1097\/TP.0000000000003654","article-title":"Safety of the first dose of SARS-CoV-2 vaccination in solid organ transplant recipients","volume":"105","author":"Boyarsky","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2025.100966_bb0215","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.cmi.2025.05.032","article-title":"Management of COVID-19 in immunocompromised patients: an European Society of Clinical Microbiology and Infectious Diseases consensus document","volume":"31","author":"Bartoletti","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.trre.2025.100966_bb0220","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.1016\/j.vaccine.2022.08.065","article-title":"SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients","volume":"40","author":"Perrier","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.trre.2025.100966_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10081563","article-title":"Analysis of the specific immune response after the third dose of mRNA COVID-19 vaccines in organ transplant recipients: possible spike-S1 reactive IgA signature in protection from SARS-CoV-2 infection","volume":"10","author":"Miele","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.trre.2025.100966_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2023.100749","article-title":"Best practices during COVID-19 pandemic in solid organ transplant programs in Spain","volume":"37","author":"Pascual","year":"2023","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.trre.2025.100966_bb0235","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac283","article-title":"Characterization of early-onset severe acute respiratory syndrome coronavirus 2 infection in immunocompromised patients who received Tixagevimab-Cilgavimab prophylaxis","volume":"9","author":"Ordaya","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.trre.2025.100966_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/v15010118","article-title":"Tixagevimab\/Cilgavimab in SARS-CoV-2 prophylaxis and therapy: a comprehensive review of clinical experience","volume":"15","author":"Akinosoglou","year":"2022","journal-title":"Viruses"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X25000667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X25000667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:54:25Z","timestamp":1763751265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X25000667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0955470X25000667"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2025.100966","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An update on SARS-CoV-2 prevention strategy in solid organ transplant recipients: an expert opinion","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2025.100966","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100966"}}